156 results
Page 5 of 8
8-K
EX-99.1
c8h0mxkx6qmbbvj0
17 Dec 14
TG Therapeutics, Inc. Announces Appointment of Kenneth Hoberman to Board of Directors
12:00am
8-K
EX-99.3
lnm0 ndx79i
9 Dec 14
Other Events
12:00am
8-K
EX-99.2
n8bz2eonb7voihns4ef
9 Dec 14
Other Events
12:00am
8-K
EX-99.1
ybvivd
9 Dec 14
Other Events
12:00am
8-K
EX-99.1
46471wbdi nhn4
10 Nov 14
TG Therapeutics, Inc. Announces Third Quarter 2014 Financial Results and Business Update
12:00am
8-K
EX-99.1
obrui9z w5shodaicgv6
15 Sep 14
Overall Response Rate (ORR) to be the Primary Endpoint to Support Accelerated Approval with Progression-Free Survival (PFS) to Support Full Approval
12:00am
8-K
EX-99.1
gs7q 2myq
21 Jul 14
Other Events
12:00am
8-K
EX-99.1
35fmd7ok4x7k7gus3a
21 Jul 14
TG Therapeutics, Inc. Announces Second Quarter 2014 Financial Results and Business Update
12:00am
8-K
EX-99.1
podf5
30 May 14
TG Therapeutics, Inc. Announces Presentation of Single Agent Data for Both TG-1101 and TGR-1202 in Ongoing Phase I Clinical Studies
12:00am
424B5
fasj34gwhrgjpnw0
12 Mar 14
Prospectus supplement for primary offering
12:00am